Clinical usefulness of VasoSeal for patients undergoing coronary intervention.

被引：0
|
作者：
Fukushima, H [1 ]
Isshiki, T [1 ]
Ichida, T [1 ]
Toyoizumi, H [1 ]
Mitani, H [1 ]
Ochiai, M [1 ]
Sato, T [1 ]
机构：
[1] Teikyo Univ, Sch Med, Dept Internal Med Cardiol, Tokyo 173, Japan
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 1998年 / 82卷 / 7A期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：110S / 110S
页数：1
相关论文
共 50 条
  • [1] Clinical usefulness of VasoSeal for patients undergoing coronary intervention (Reprinted from American Journal of Cardiology, vol 82, pg 110S, 1998)
    Fukushima, H
    Isshiki, T
    Ichida, T
    Toyoizumi, H
    Mitani, H
    Ochiai, M
    Sato, T
    JOURNAL OF INVASIVE CARDIOLOGY, 1999, 11 : 4B - 4B
  • [2] Clinical outcomes associated with the use of bivalirudin for patients with acute coronary syndrome undergoing early percutaneous coronary intervention.
    Barman, N
    Gurm, H
    Bhatt, D
    Lincoff, AM
    Ellis, S
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (6A): : 191E - 191E
  • [3] Contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention.
    Jurado, Alfonso
    Hernandez, Felipe
    Garcia-Tejada, Julio
    Albarran, Agustin
    Teresa Velazquez, M.
    Granda, Carolina
    Belen, Diaz
    Rubio, Belen
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (18) : B109 - B109
  • [4] Abciximab reduces procedure time among patients undergoing percutaneous coronary intervention.
    Cabot, CF
    Anderson, KM
    Tcheng, JE
    Lincoff, AM
    AMERICAN JOURNAL OF CARDIOLOGY, 1999, 84 (6A): : 71P - 71P
  • [5] Prognostic value and clinical usefulness of PIANO score in patients undergoing primary percutaneous coronary intervention
    Dai, Chunfeng
    Yang, Zheng
    Liu, Muyin
    Zhou, You
    Lu, Danbo
    Chang, Shufu
    Li, Chenguang
    Lu, Hao
    Chen, Zhangwei
    Qian, Juying
    Ge, Junbo
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2023, 390
  • [6] Sustained benefit of fenoldopam on renal function in patients undergoing percutaneous coronary intervention.
    Kini, AS
    Agarwal, A
    Mukaddam, S
    Lee, P
    Mitre, CA
    Attanti, S
    Duffy, ME
    Kim, MC
    Sharma, SK
    AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (6A): : 144H - 145H
  • [7] Clinical and genetic predictors of anti-platelet therapy selection in coronary artery disease patients undergoing percutaneous coronary intervention.
    Varunok, Nicholas
    Hamrick, Kasey
    Polasek, Melissa
    Lee, John Andrew
    Wells, Michael
    Cervantes, Alexandra
    Sriramoju, Vindhya B.
    Howell, Lucius
    Stouffer, George A.
    Lee, Craig
    PHARMACOTHERAPY, 2016, 36 (07): : E112 - E113
  • [8] Metabolic syndrome and risk of in-stent restenosis in patients undergoing percutaneous coronary intervention.
    Ha, J. K.
    Lee, H. C.
    Kim, J.
    Kim, J. H.
    Chun, K. J.
    Hong, T. J.
    Shin, Y. W.
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (08): : 79F - 80F
  • [9] Desensitization to Acetylsalicylic Acid in Patients Undergoing Percutaneous Coronary Intervention. Experience in a Tertiary Center
    Diez-Villanueva, Pablo
    Pineda, Rafael
    Sanchez, Pedro L.
    Tornero, Pilar
    Fernandez-Aviles, Francisco
    REVISTA ESPANOLA DE CARDIOLOGIA, 2014, 67 (06): : 494 - 496
  • [10] Aspirin Hypersensitivity in Patients Undergoing Percutaneous Coronary Intervention. What Should We be Doing?
    Kassimis, George
    Raina, Tushar
    Alexopoulos, Dimitrios
    CURRENT VASCULAR PHARMACOLOGY, 2019, 17 (04) : 326 - 331
12345